 Novo Nordisk AS NVO ADA 82nd Scientific Sessions Conference June 5, 2022 8:30 PM ET Company Participants Karsten Knudsen - Chief Financial Officer Martin Holst Lange - EVP and Head of Development Mads Frederik Rasmussen - Senior Vice President and Head of Clinical Drug Development Conference Call Participants Michael Novod - Nordea Markets Richard Vosser - JPMorgan Chase Co Mark Purcell - Morgan Stanley Michael Nedelcovych - Cowen and Company Jesper Ilsoe - Carnegie Karsten Knudsen Welcome to the Novo Nordisk RD event in conjunction with the ADA 2022 here in New Orleans in hot summer June. Its great to see all here, and we have a very nice RD presentation coming up. 